Asterwood

The first bottles were mixed at a childhood home. When Angela Norden began testing anti-aging formulas, the operation was literally a family kitchen-table affair, with early product blended and filled where she and her brother had grown up. That detail explains a lot about the brand's eventual personality: there was no investor deck, no brand consultant, no luxury-positioning workshop, just a sibling team trying to make something that worked and could be sold for far less than the department-store serums charging triple-digit prices for the same commodity actives. The strategic insight was choosing radical simplicity over the trend toward elaborate multi-ingredient "complexes." Each product was built around a single, recognizable, well-studied active named plainly on the label, so a buyer comparing a hyaluronic acid or a peptide serum could see exactly what they were paying for. On a marketplace where confused shoppers default to clear labeling and stacks of reviews, that transparency became a competitive moat. The line leaned into being a marketplace-native business rather than fighting for shelf space or magazine spreads, and it grew into a high-volume name selling not only to consumers but reportedly to skincare professionals buying in quantity. By the time it reached mid-seven-figure revenue with notably strong repeat-purchase rates, it had proven a thesis that the beauty establishment often resists: that a no-frills, value-priced single-active serum, backed by genuine customer loyalty rather than marketing spend, could scale. That track record is precisely what made it an acquisition target for an aggregator that specializes in buying and growing exactly this kind of proven, review-rich marketplace business, folding a kitchen-table experiment into a professionally managed portfolio while keeping its plainspoken value proposition intact.

Sources:[1][2][3]